Could a diabetes drug protect the heart in atrial fibrillation patients?
NCT ID NCT07482020
First seen Apr 11, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study tests whether a type of diabetes medication (SGLT2 inhibitors) can improve the heart's upper chamber function and help prevent heart failure in people with intermittent atrial fibrillation, high blood pressure, and abnormal blood sugar. About 66 adults will receive either the drug or a placebo, and their heart function will be measured using advanced ultrasound. The goal is to find a new way to reduce heart failure risk in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Affiliated Huashan Hospital, Cardiology Department
RECRUITINGShanghai, Shanghai Municipality, 200036, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.